Get the Stockscreener App
1.78
2.89%
0.05
After Hours:
1.79
0.01
+0.56%
Senti Biosciences Inc stock is traded at $1.78, with a volume of 129.97K.
It is up +2.89% in the last 24 hours and up +34.85% over the past month.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
See More
Previous Close:
$1.73
Open:
$1.73
24h Volume:
129.97K
Relative Volume:
0.57
Market Cap:
$46.57M
Revenue:
$1.79M
Net Income/Loss:
$-70.90M
P/E Ratio:
-0.1145
EPS:
-15.54
Net Cash Flow:
$-34.95M
1W Performance:
+23.61%
1M Performance:
+34.85%
6M Performance:
-41.25%
1Y Performance:
-25.21%
1-Day Range:
$1.66
$1.7895
1-Week Range:
$1.432
$1.7895
52-Week Range:
$1.26
$16.94
Senti Biosciences Inc Stock (SNTI) Company Profile
Name
Senti Biosciences Inc
Sector
Industry
Phone
(650) 239-2030
Address
2 CORPORATE DRIVE, FIRST FLOOR, SOUTH SAN FRANCISCO
Compare SNTI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SNTI
Senti Biosciences Inc
|
1.78 | 45.26M | 1.79M | -70.90M | -34.95M | -15.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.15 | 105.19B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
450.68 | 60.24B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.86 | 61.82B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
798.94 | 49.09B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
351.09 | 37.52B | 4.56B | -176.77M | 225.30M | -1.7177 |
Senti Biosciences Inc Stock (SNTI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-06-25 | Initiated | Laidlaw | Buy |
| Oct-07-22 | Initiated | Morgan Stanley | Equal-Weight |
Senti Biosciences Inc Stock (SNTI) Latest News
Is Senti Biosciences Inc a good long term investmentMarket Depth Overview & Low Entry Investment Growth - earlytimes.in
Senti Bio to Present at BioJapan - MarketScreener
Oct 9, 11:30 JST — Senti Biosciences presents at BioJapan; CEO Timothy Lu to speak, booth D-53 - Stock Titan
Using data models to predict Senti Biosciences Inc. stock movementTrade Entry Report & Verified Swing Trading Watchlist - newser.com
Custom strategy builders for tracking Senti Biosciences Inc.July 2025 Momentum & Risk Adjusted Swing Trade Ideas - newser.com
What analysts say about Senti Biosciences Inc stockStop Loss Placement Tips & High Yield Trading Signals - earlytimes.in
Is Senti Biosciences Inc. a candidate for recovery playRate Hike & Entry Point Strategy Guides - newser.com
Statistical indicators supporting Senti Biosciences Inc.’s strengthWeekly Trade Analysis & Reliable Volume Spike Trade Alerts - newser.com
Price action breakdown for Senti Biosciences Inc.Market Sentiment Report & Community Trade Idea Sharing Platform - newser.com
Senti Biosciences Inc Stock Analysis and ForecastEconomic Impact on Stocks & Free Unmatched Market Gains - earlytimes.in
Is It Time to Lock in Profits on Setco Automotive Limited StockRisk Mitigation Techniques & Big Data Market Reports - earlytimes.in
What drives Senti Biosciences Inc stock priceInsider Trading Activity & Low Cost Trading Ideas - earlytimes.in
Real time scanner hits for Senti Biosciences Inc. explainedWeekly Profit Report & Fast Moving Market Watchlists - newser.com
Visual analytics tools that track Senti Biosciences Inc. performanceJuly 2025 Trade Ideas & Free Technical Confirmation Trade Alerts - newser.com
Published on: 2025-09-22 13:38:16 - newser.com
Real time breakdown of Senti Biosciences Inc. stock performanceRecession Risk & AI Based Trade Execution Alerts - newser.com
Published on: 2025-09-21 09:20:53 - newser.com
Is Senti Biosciences Inc. stock reversal real or fake2025 Retail Activity & Free Accurate Trade Setup Notifications - newser.com
How institutional ownership impacts Senti Biosciences Inc. stock2025 Analyst Calls & Weekly High Momentum Picks - newser.com
Revenue Check: Is Senti Biosciences Inc benefiting from innovation trendsQuarterly Earnings Report & Short-Term High Return Ideas - khodrobank.com
Risks Report: Is Senti Biosciences Inc affected by consumer sentiment2025 Bull vs Bear & Long-Term Growth Portfolio Plans - خودرو بانک
Price Action: What are the analyst revisions for Senti Biosciences Inc.Is ICON stock a good investment in YEARQuarterly Profit Report & Weekly Top Gainers Trade List - خودرو بانک
Quantitative breakdown of Senti Biosciences Inc. recent moveWeekly Risk Report & Free Risk Controlled Daily Trade Plans - newser.com
What’s next for Senti Biosciences Inc. stock pricePortfolio Profit Report & AI Based Buy/Sell Signal Reports - newser.com
Will Senti Biosciences Inc. stock go up soonQuarterly Profit Report & Reliable Trade Execution Plans - newser.com
Growth Recap: Should I trade or invest in Senti Biosciences Inc2025 Valuation Update & Daily Profit Maximizing Trade Tips - خودرو بانک
Market reaction to Senti Biosciences Inc.’s recent newsM&A Rumor & AI Based Trade Execution Alerts - newser.com
Market Pulse: Does Senti Biosciences Inc have a sustainable dividend2025 Technical Patterns & Verified Momentum Stock Ideas - خودرو بانک
Signal strength of Senti Biosciences Inc. stock in tech scannersJuly 2025 Macro Moves & High Conviction Buy Zone Alerts - newser.com
Senti Biosciences Inc Stock (SNTI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Senti Biosciences Inc Stock (SNTI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Lu Timothy K | CEO |
Feb 06 '25 |
Sale |
4.36 |
545 |
2,376 |
82,082 |
| Rajangam Kanya | Pres. & Chief Med. & Dev. Off. |
Feb 04 '25 |
Sale |
4.07 |
1,297 |
5,279 |
8,803 |
| Rajangam Kanya | Pres. & Chief Med. & Dev. Off. |
Feb 06 '25 |
Sale |
4.37 |
182 |
795 |
8,621 |
2.05%
4.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):